Sapporo, Japan

Yoshiro Chuman

This inventor holds 1 USPTO granted patent. Top assignee: Lsip, LLC. Active years: 2014.


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yoshiro Chuman: Innovator in Protein Phosphatase Inhibition

Introduction

Yoshiro Chuman is a notable inventor based in Sapporo, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of protein phosphatase inhibitors. His innovative work has led to the creation of a novel compound that holds promise for various applications in medical and biochemical research.

Latest Patents

Yoshiro Chuman holds a patent for a protein phosphatase inhibitor. This inhibitor contains, as an active ingredient, a silicon compound represented by a specific general formula. The formula includes hydrocarbon groups and heterocyclic groups, showcasing the complexity and potential of his invention. This patent is a testament to his expertise and dedication to advancing scientific knowledge.

Career Highlights

Throughout his career, Yoshiro Chuman has been associated with Lsip, LLC, where he has furthered his research and development efforts. His work has not only contributed to his personal achievements but has also enhanced the reputation of his organization in the field of biochemistry.

Collaborations

Yoshiro Chuman has collaborated with esteemed colleagues such as Kazuyasu Sakaguchi and Keiji Tanino. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, ultimately leading to groundbreaking advancements in their field.

Conclusion

Yoshiro Chuman's contributions to the development of protein phosphatase inhibitors highlight his role as a leading inventor in biochemistry. His innovative spirit and collaborative efforts continue to inspire advancements in scientific research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…